Alzheimer Disease Early-onset
📧 Sign up to get email alerts when something new happens for Alzheimer Disease Early-onset.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-07-28Clinical Trial Update: SNIFF - 3-Week Aptar CPS Device [Phase 2]
A Phase 2 clinical trial of the SNIFF 3-Week Aptar CPS device sponsored by Wake Forest University Health Sciences has been withdrawn.